indirubin-3'-monoxime has been researched along with Multiple Myeloma in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, Z | 1 |
| Wei, X | 1 |
| Liu, L | 1 |
| Sun, H | 1 |
| Fang, T | 1 |
| Wang, L | 1 |
| Li, Y | 1 |
| Sui, W | 1 |
| Wang, K | 1 |
| He, Y | 1 |
| Zhao, Y | 1 |
| Huang, W | 1 |
| An, G | 1 |
| Meng, F | 1 |
| Huang, C | 1 |
| Yu, T | 1 |
| Anderson, KC | 1 |
| Cheng, T | 1 |
| Qiu, L | 1 |
| Hao, M | 1 |
1 other study available for indirubin-3'-monoxime and Multiple Myeloma
| Article | Year |
|---|---|
Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma.
Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; I | 2022 |